Nitroglycerin Tablet
Product Images NDC 71872-7033

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nitroglycerin (NDC 71872-7033). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Pdp (71872 7033 1 Pdp)

Pdp (71872 7033 1 Pdp)
This is a product description for Nitroglycerin sublingual tablets, with a strength of 0.4 mg per tablet and each bottle containing 25 sublingual tablets. The storage requirements for the medicine are 20°-25°C. Patients may feel a burning or tingling sensation upon taking the tablets, but this is normal. If the pain persists after taking three tablets in a 15-minute period or is more severe than typical, medical attention is recommended. The tablets must be kept in their original container or in a supplemental nitroglycerin container and should not be crushed, chewed, or swallowed. The tablets are manufactured by Glonmark Pharmaceuticals for Glanmark Pharmaceuticals Inc in the USA. The text also mentions a manufacturer NDC number and that the product is distributed by Repackaged Medical Purchasing Solutions.*
FDA Label Image

Z:\regulatory Affairs 2\andas\nitroglycerin Sl Tablets (206391)\_misc\rld Update\0.4mg25ct.jpg (78127b18 3d0f 4a21 884d Eb7ca2d38b13 02)

Z:\regulatory Affairs 2\andas\nitroglycerin Sl Tablets (206391)\_misc\rld Update\0.4mg25ct.jpg (78127b18 3d0f 4a21 884d Eb7ca2d38b13 02)
FDA Label Image

Z:\regulatory Affairs\_compliance\drug Listings\electronic\gateway Submissions\nitroglycerin Sl Tablets\version 7\image-01.jpg (78127b18 3d0f 4a21 884d Eb7ca2d38b13 06)

Z:\regulatory Affairs\_compliance\drug Listings\electronic\gateway Submissions\nitroglycerin Sl Tablets\version 7\image-01.jpg (78127b18 3d0f 4a21 884d Eb7ca2d38b13 06)
FDA Label Image

Z:\regulatory Affairs\_compliance\drug Listings\electronic\gateway Submissions\nitroglycerin Sl Tablets\version 7\image-01.jpg (78127b18 3d0f 4a21 884d Eb7ca2d38b13 07)

Z:\regulatory Affairs\_compliance\drug Listings\electronic\gateway Submissions\nitroglycerin Sl Tablets\version 7\image-01.jpg (78127b18 3d0f 4a21 884d Eb7ca2d38b13 07)
FDA Label Image

Z:\regulatory Affairs\_compliance\drug Listings\electronic\gateway Submissions\nitroglycerin Sl Tablets\version 7\structure.jpg (78127b18 3d0f 4a21 884d Eb7ca2d38b13 08)

Z:\regulatory Affairs\_compliance\drug Listings\electronic\gateway Submissions\nitroglycerin Sl Tablets\version 7\structure.jpg (78127b18 3d0f 4a21 884d Eb7ca2d38b13 08)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.